Studies on the extra-mitochondrial CoA -ester formation of valproic and Delta4 -valproic acids.
The hypothesis whether valproic acid (VPA) and its main microsomal metabolite, Delta(4)-valproic acid, can be activated to the respective CoA esters in the cell cytosol was investigated. The valproyl-CoA formation was measured in different subcellular fractions obtained by differential centrifugation of liver homogenates of rats treated with VPA (studies ex vivo) and digitonin fractionation of rat hepatocytes incubated with VPA and cofactors (studies in vitro). The results show that VPA activation may occur in the cytosol and is not restricted to the mitochondrial matrix as believed until now. Furthermore, the activation of Delta(4)-VPA is demonstrated in vitro. Valproyl-CoA and Delta(4)-valproyl-CoA were detected after in vitro incubations and the former also in the mitochondrial and cytosolic fractions obtained from liver cells of treated rats. The activation to valproyl-CoA was characterized in cytosolic fractions, optimized with respect to time and protein and the kinetic constants (K(m)(app)) were estimated for the reaction substrates. Other medium-chain fatty acids decreased the formation of valproyl-CoA suggesting a competition for both mitochondrial and extra-mitochondrial VPA activating enzymes. The present findings suggest additional mechanisms of mitochondrial dysfunction associated with VPA, and they may contribute to the further understanding of the toxic effects associated with this drug.
Aires
Cátia C P
CC
UBMBE, Centro de Patogénese Molecular, Faculdade de Farmácia da Universidade de Lisboa, Av Prof Gama Pinto, Lisboa, Portugal.
Ruiter
Jos P N
JP
Luís
Paula B M
PB
ten Brink
Herman J
HJ
Ijlst
Lodewijk
L
de Almeida
Isabel Tavares
IT
Duran
Marinus
M
Wanders
Ronald J A
RJ
Silva
Margarida F B
MF
D000214:Acyl Coenzyme A / Q000378:metabolism*; D000818:Animals; D002851:Chromatography, High Pressure Liquid; D002950:Citrate (si)-Synthase / Q000378:metabolism; D003065:Coenzyme A / Q000378:metabolism; D003600:Cytosol / Q000187:drug effects / Q000201:enzymology; D004952:Esters; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012015:Reference Standards; D013997:Time Factors; D014635:Valproic Acid / Q000031:analogs & derivatives* / Q000302:isolation & purification / Q000378:metabolism* / Q000494:pharmacology
D000214:Acyl Coenzyme A; D004952:Esters; C045335:valproyl-coenzyme A; C015787:dephosphocoenzyme A; D014635:Valproic Acid; D002950:Citrate (si)-Synthase; D003065:Coenzyme A